Cross-Sector entity
Of the tracked stories, 3 of 5 also mention Donald Trump, the most common co-covered peer. The 38-day window averages about 0.9 stories each week. The busiest single day carried 2. The clearest coverage concentration is regulation: 2 of 5 stories, with the rest divided among 3 other categories.
5 verified stories tracked
Last mentioned: Aug 4, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 20 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 3 of 5 also mention Donald Trump, the most common co-covered peer. The 38-day window averages about 0.9 stories each week. The busiest single day carried 2. The clearest coverage concentration is regulation: 2 of 5 stories, with the rest divided among 3 other categories. Negative sentiment appears in 20% of the tracked stories. Each carries 4 original sources on average. Bill Cassidy appears in 5 tracked Cross-Sector stories published from June 28, 2026 through August 4, 2026.
Computed from the 5 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bill Cassidy. Shared-story counts are live from our verified record — not editorial picks.
Senator Bill Cassidy, a physician and key vote for RFK Jr.'s HHS confirmation, now accuses the secretary of building public health on a 'foundation of lies' and violating commitments. The rift threatens public trust in health agencies and could destabilize federal disease prevention guidance for hospitals and providers.
Senator Bill Cassidy's public denouncement of HHS Secretary Kennedy for building health policy on lies injects fresh uncertainty into the biotech and pharma industry. Vaccine research and markets face headwinds if top federal officials continue to sow distrust, potentially altering investment and development pipelines.
Source: cbsnews.com · yahoo.com
The CDC faces a pivotal leadership moment with Dr. Erica Schwartz’s nomination amid a 25% staff loss and political tensions. Her confirmation could shape the agency’s capacity to control outbreaks and restore scientific credibility.
Source: listenupyall.com · theyeshivaworld.com
Sen. Bill Cassidy's proposal to invest $1.5 trillion in a market fund targets the 22% benefit cut facing Social Security in 2032. HR leaders must evaluate how the looming solvency crisis—and potential fixes—will reshape employees' retirement planning and employer benefits obligations.
A historic Senate vote aims to halt US military operations against Iran, casting uncertainty over the Pentagon's $80 billion funding request. The resolution, though symbolic, signals deep GOP fractures and potential delays for critical defense programs.
Source: abc7ny.com · arabnews.com
